COVID-19 Funding (03-23-2020)

Mar 23, 2020, 16:33 PM by Melodi Moore

FUNDING OPPORTUNITIES PERTAINING TO CORONA VIRUS


https://www.grants.gov/web/grants/search-grants.html?keywords=Coronavirus

Updated: 10/23/2020 (all new/revised opportunities listed first)

 

 

Agency

Opp Number

Name of solicitation

Application Due Date

Notes

NEW/REVISED

 

 

 

 

BARDA

BARDA-BAA

Advanced development and licensure of COVID-19 diagnostics, vaccines or medicines, such as therapeutics or antivirals.

4/30/2020

Added due date

CDC

75D301-20-R-67897

Broad Agency Announcement (BAA) Applied Research to Address The Coronavirus (COVID-19)

Emerging Public Health Emergency

03/25/2020

Immediate call for White papers.

NIAID

NIAID-BAA2020-1

2020 NIAID Omnibus Broad Agency Announcement

04/09/2020

Extended deadlines in specific areas only

NIAID

NOT-AI-20-030

Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

----------

Rolling deadlines

NIAID

RFA-AI-20-028

Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)

06/29/2020

Mandatory LOI due 05/29/2020

NIAID

PAR-18-781

Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trial Not Allowed)

09/09/2020

 

NIDA

NOT-DA-20-047

Availability of Administrative Supplements and Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus

-------

Supplement to existing awards.

Rolling deadlines. Especially interested in research collecting and examining data on the risks and outcomes for COVID-19 infection in individuals suffering from substance use disorders.

NHLBI

NOT-HL-20-757

Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19)

------

Supplement to existing awards.

Rolling deadlines. Topics of specific interest to NHLBI include SARS-CoV-2 host response, associations with heart, lung, and blood (HLB) diseases, potential impacts on transfusion safety, and clinical outcomes of infected individuals.

NIA

NIAID

NIDDK

NIDA

NIMH

NIEHS

NICHD

NIAAA

PA-18-935

Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)

------

Continuous submission. Earliest start dates may vary by awarding IC. See the Urgent Guide Notices for any applicable Application Due Dates.

NIAID

NIA

PAR-20-139

Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)

05/13/2020

 

NIHR (UK)

Travel Funds

Travel and subsistence funding to support delivery of technical expertise in the global response to Covid-19.

05/30/2020

Continuous submission. For UK collaborations only

 

 

 

 

 

 

 

Previous Postings

 

 

 

 

HHS-CDC-OSTLTS

CDC-RFA-OT18-18020202SUPP20

Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health

04/02/2020

 

DOE

Dear Colleague Letter

DOE mission complements the efforts of the National Institutes of Health, the Department of Defense, and other Federal partners by helping to understand the scientific phenomena contributing to COVID-19, from the structure of the SARS-CoV-2 virus, which causes the disease, to models that can mimic its spread.

Responses accepted starting March 18, 2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2113

Expanding Efforts and Strategies to Protect and Improve Public Health inVietnam

5/11/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2125

Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health in the Democratic Republic of the Congo (DRC)

5/12/2020

 

HHS-CDC-OSTLTS*

CDC-RFA-OT18-18020202SUPP20

Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health

4/2/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2124

Improving Health Security and Building International Health Regulations core capacities in the Republic of Uganda

5/12/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2115

Expanding Efforts and Strategies to Protect and Improve Public Health in Kenya

5/11/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2118

Global Health Security through Strengthened Community Based Surveillance

5/11/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2131

Strengthening Regional Field Epidemiology Training Program (FETP) Networks

5/4/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2119

Global Health Security Partner Enhancement : Expanding Efforts to Improve Surveillance and Laboratory Data Interoperability

5/4/2020

 

DHHS/CDC

CDC-RFA-OT18-18020202SUPP20

Strengthening Public Health Systems and Services through National Partnerships to Improve and Protect the Nations Health

3/20/2020

 

USAID

7200AA20RFA00007

STOP Spillover

N/A

 

DHHS/CDC

CDC-RFA-GH20-2093

Protecting and Improving Public Health Globally: Building and Strengthening Public Health Impact, Health Systems, Capacity Building, and Health Security in Cote d’Ivoire

04/07/20 11:59 ET

 

DHHS/CDC

CDC-RFA-GH20-2094

Advancing Ethiopia's Capacity for Laboratory, Workforce Development, Surveillance, and Emergency Management to meet International Health Regulations requirements

04/07/2020 11:59 ET

 

DHHS/CDC

CDC-RFA-GH20-2095

Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India

04/27/2020 11:59 ET

 

DHHS/CDC

CDC-RFA-GH20-2108

Strengthening Global Field Epidemiology Training Program (FETP) Network

04/27/2020 11:59 ET

 

DHHS/CDC

CDC-RFA-GH20-2107

Building Capacity for National Public Health Institutes

5/4/2020

 

DHHS/CDC

CDC-RFA-GH20-2109

Global Health Security Partnerships: Expanding and Improving Public Health Laboratory Strategies and Systems.

5/4/2020

 

DHHS/CDC

CDC-RFA-GH20-2122

Strengthening Sustainability of Global Health Security Objectives in Sierra Leone

5/4/2020

 

DHHS/CDC

CDC-RFA-GH20-2092

Global Health Security Partnership Engagement: Expanding Efforts and Strategies to Protect and Improve Public Health in Cameroon

4/7/2020

 

DHHS/CDC

CDC-RFA-GH20-2126

Strengthening Global Health Security by implementation of the International Health Regulations (IHR) (2005) and the Global Health Security Agenda in Nigeria

4/27/2020

 

DHHS/CDC

CDC-RFA-GH20-2110

Enhancing Global Health Security: Expanding Efforts and Strategies to Protect and Improve Public Health Globally

4/27/2020

 

DHHS/CDC

CDC-RFA-GH20-2091

Accelerating Sustainability of Public Health Systems in India to Prevent, Detect, and Respond to Infectious Disease Outbreaks and Other Public Health Emergencies

4/27/2020

 

DHHS/CDC

CDC-RFA-GH20-2101

Tanzania Global Health Security Partner Engagement: Advancing Efforts and Strategies to Protect and Improve Public Health

4/27/2020

 

HHS-NIH11

RFA-AI-20-009

Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)

5/29/2020

 

HHS-CDC-CGH

CDC-RFA-GH20-2095

Strengthening Laboratory Systems to Establish Routine Laboratory based surveillance for Priority Infectious Diseases in India

4/27/2020

 

HHS-NIH11

PAR-20-108

International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)

8/19/2022

 

NIH Funding

 

 

 

 

NIH/NIAID/NIA

PAR-20-139

Invites applications for implementation of investigator-initiated clinical trials requiring an extended project period of 6 or 7 years. The trials can be any phase, must be hypothesis-driven, and related to the research mission of one of the participating ICs.

05/13/2020

 

NIH/NIAID/ NIGMS

NOT-AI-20-030

Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions for Research on the 2019 Novel Coronavirus (2019-nCoV)

Immediate

 

NIH/NIAID

RFA-AI-20-021

Vaccine and Treatment Evaluation Units (VTEUs): Enhancing Capability and Capacity (UM1 Clinical Trial Required)

04/14/2020

 

NIH/NIAID

RFA-AI-20-009

Three-Dimensional (3D) Human Biomimetics for Infectious Diseases (U19 Clinical Trial Not Allowed)

05/29/2020

 

NIH/NIAID

RFA-AI-20-003

Partnerships for the Development of Universal Influenza Vaccines (R21/R33 Clinical Trial Not Allowed)

06/02/2020

 

NIH/NIAID

RFA-AI-20-008

Multidisciplinary Studies to Improve Understanding of Influenza Transmission (U19 Clinical Trial Optional)

06/23/2020

 

NIH/Multiple Institutes

PA-18-591

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)

Contact Program Officer

 

NIH/Fogarty International Center

 

Ecology and Evolution of Infectious Diseases Initiative (EEID)

11/18/2020

 

OTHER FEDERAL AGENCIES

 

 

 

NSF

Letter to Researchers

To conduct non-medical, non-clinical-care research that can be used immediately to explore how to model and understand the spread of COVID-19, to inform and educate about the science of virus transmission and prevention, and to encourage the development of processes and actions to address this global challenge.

Immediate

 

PRIVATE FUNDING

 

 

 

Bill & Melinda Gates Foundation, Wellcome, and Mastercard COVID-19 Therapeutics Accelerator

 

$125 million to speed-up the response to the COVID-19 epidemic by identifying, assessing, developing, and

scaling-up treatments.